CHI3L1 and Alzheimer disease: Accumulating evidence suggests that CHI3L1 plays a role in the formation and aggregation of Aβ plaques, a hallmark of AD pathology, by modulating microglial phagocytosis and the clearance of Aβ peptides [136, 137].